We are live on
!
Find out more
PAWC
P.A.W. Capital Portfolio holdings
AUM
$131M
1-Year Est. Return
46.14%
This Fund
S&P 500
This Quarter
Est. Return
+11.61%
1 Year Est. Return
+46.14%
3 Year Est. Return
+67.18%
5 Year Est. Return
+64.85%
10 Year Est. Return
+1,459.33%
AUM
$36.6M
AUM Growth
-$30.1M
(-45%)
Cap. Flow
-$28.5M
Cap. Flow
% of AUM
-77.87%
Top 10 Holdings %
Top 10 Hldgs %
70.76%
Holding
58
New
2
Increased
3
Reduced
11
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NEXN
Nexxen International
NEXN
|
+$1.45M |
| 2 |
DocGo
DCGO
|
+$1.34M |
| 3 |
Allot
ALLT
|
+$188K |
| 4 |
GameSquare
GAME
|
+$156K |
| 5 |
Digital Turbine
APPS
|
+$154K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Magnite
MGNI
|
+$2.46M |
| 2 |
Ambarella
AMBA
|
+$1.66M |
| 3 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
+$1.16M |
| 4 |
Shell
SHEL
|
+$896K |
| 5 |
ExxonMobil
XOM
|
+$873K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.65% |
| 2 | Communication Services | 30.55% |
| 3 | Healthcare | 10.16% |
| 4 | Industrials | 9.78% |
| 5 | Consumer Discretionary | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
AbbVie
ABBV
$443B
| – | – |
-5,500
| Closed | -$738K |
|
27
Amgen
AMGN
$208B
| – | – |
-3,600
| Closed | -$811K |
|
28
Ares Capital
ARCC
$13.5B
| – | – |
-48,000
| Closed | -$810K |
|
29
Bristol-Myers Squibb
BMY
$133B
| – | – |
-12,000
| Closed | -$853K |
|
30
Cognition Therapeutics
CGTX
$79.6M
| – | – |
-100,000
| Closed | -$190K |
|
31
Cisco
CSCO
$457B
| – | – |
-20,000
| Closed | -$800K |
|
32
Chevron
CVX
$392B
| – | – |
-6,000
| Closed | -$862K |
|
33
Dow Inc
DOW
$21.9B
| – | – |
-18,000
| Closed | -$791K |
|
34
Enbridge
ENB
$119B
| – | – |
-20,000
| Closed | -$742K |
|
35
Goldman Sachs
GS
$300B
| – | – |
-2,800
| Closed | -$821K |
|
36
GSK
GSK
$104B
| – | – |
-27,500
| Closed | -$809K |
|
37
Johnson & Johnson
JNJ
$618B
| – | – |
-5,000
| Closed | -$817K |
|
38
JPMorgan Chase
JPM
$935B
| – | – |
-7,500
| Closed | -$784K |
|
39
Lockheed Martin
LMT
$134B
| – | – |
-2,000
| Closed | -$773K |
|
40
3M
MMM
$90.9B
| – | – |
-8,970
| Closed | -$829K |
|
41
Altria Group
MO
$114B
| – | – |
-20,000
| Closed | -$808K |
|
42
Merck
MRK
$322B
| – | – |
-10,000
| Closed | -$861K |
|
43
Morgan Stanley
MS
$331B
| – | – |
-11,000
| Closed | -$869K |
|
44
Microsoft
MSFT
$3.45T
| – | – |
-3,000
| Closed | -$699K |
|
45
Omega Healthcare
OHI
$15.1B
| – | – |
-28,000
| Closed | -$826K |
|
46
PepsiCo
PEP
$190B
| – | – |
-5,000
| Closed | -$816K |
|
47
Pfizer
PFE
$143B
| – | – |
-18,000
| Closed | -$788K |
|
48
Procter & Gamble
PG
$336B
| – | – |
-5,500
| Closed | -$694K |
|
49
Philip Morris
PM
$297B
| – | – |
-9,000
| Closed | -$747K |
|
50
Prudential Financial
PRU
$42.4B
| – | – |
-9,000
| Closed | -$772K |
|
Similar funds
EIM
CIP
AC
ADEF
LC
EWP
OIM
EPI
P.A.W. Capital's Q4 2022 Portfolio in Review
As of Q4 2022, P.A.W. Capital held 58 positions worth $36.6M, down 45% from $66.7M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
P.A.W. Capital withdrew a net $28.5M in Q4 2022, closing 33 positions and reducing 11 holdings. Its most notable exit was Shell, an estimated $896K position sold in full.
By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 31% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, P.A.W. Capital opened a new position in Nexxen International worth $1.28M.
- P.A.W. Capital's largest Q4 2022 buy was Nexxen International: 198,658 shares worth $1.28M.
- P.A.W. Capital added most to Allot in Q4 2022, an estimated $188K increase.
- P.A.W. Capital's biggest Q4 2022 reduction was Magnite, cutting an estimated $2.46M.
- P.A.W. Capital fully exited Shell in Q4 2022, selling an estimated $896K.
- P.A.W. Capital's ten largest holdings make up 71% of its $36.6M portfolio in Q4 2022.
- P.A.W. Capital opened 2 new positions and closed 33 in Q4 2022.
- P.A.W. Capital's portfolio value fell 45% quarter-over-quarter to $36.6M.
Based on P.A.W. Capital's 13F filing for Q4 2022, filed 14 Feb 2023.